Inkatuuli Heikkinen

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Transcription Factor

Health Promotion

Clinical Evaluation

Helicobacter Pylori Infection

Top Venues

International journal of technology assessment in health care

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Milou Amber Hogervorst, Rick A Vreman, Inkatuuli Heikkinen, Indranil Bagchi, Iñaki Gutierrez-Ibarluzea, Bettina Ryll, Hans-Georg Eichler, Elena Petelos, Sean Tunis, Claudine Sapede, Wim G Goettsch, Rosanne Janssens, Isabelle Huys, Liese Barbier, Deirdre DeJean, Valentina Strammiello, Dimitra Lingri, Melinda Goodall, Magdalini Papadaki, Massoud Toussi, Despina Voulgaraki, Ania Mitan, Wija Oortwijn
UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP. International journal of technology assessment in health care (2023)
Milou Amber Hogervorst, Rick A Vreman, Inkatuuli Heikkinen, Wija Oortwijn
Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply. International journal of technology assessment in health care 40 (1) (2023)
Milou Amber Hogervorst, Rick A Vreman, Inkatuuli Heikkinen, Wija Oortwijn
RESPONSE TO UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP - AUTHOR'S REPLY. International journal of technology assessment in health care (2023)
Milou Amber Hogervorst, Rick A Vreman, Inkatuuli Heikkinen, Wija Oortwijn
Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply. International journal of technology assessment in health care 40 (1) (2023)
Milou Amber Hogervorst, Rick A Vreman, Inkatuuli Heikkinen, Wija Oortwijn
Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply. International journal of technology assessment in health care 40 (1) (2023)
Inkatuuli Heikkinen, Aimad Torqui
Acceptance of stakeholder comments during EMA scientific guideline public consultations: Legitimacy of the quadruple helix model of innovation. British journal of clinical pharmacology (2022)